Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pheochromocytoma 1Endocrine System Diseases 1

Interventions

gallium Ga 68 dotatate 4lutetium Lu 177 dotatate 2belzutifan 2Fluorodeoxyglucose F18 23-fluorobenzylguanidine 2olaparib 1fluorodopa F 18 1fludarabine phosphate 1Specimen Handling 1Phenoxybenzamine 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Genetic Testing 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 16-fluorodopamine 13-Iodobenzylguanidine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pheochromocytoma × 6-fluorodopamine × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡